CKM Health for Professionals
Cardiovascular-kidney-metabolic (CKM) syndrome is a health disorder made up of heart disease, kidney disease, diabetes and obesity, leading to poor health outcomes.
Groundbreaking new therapies exist, but many patients experience fragmented care. By recognizing CKM as a connected syndrome, we can shift from reactive care to earlier detection, coordinated treatment, and better outcomes
Toolkits
Access toolkits to improve CKM care and outcomes
-
Screening for Kidney Disease to Reduce CVD Risk
Enhance collaboration and communication across care teams with a toolkit designed to improve patient understanding. Explore practical guidance on CKD causation, prevalence, hidden disease burden, diabetes risk, CVD risk, GDMT and additional key topics.
-
Cardiovascular-Kidney-Metabolic Health Implementation Guide
1 in 3 adults faces high CKM risk. This toolkit helps bring the science to life in clinic with practical, cross-specialty guidance for identifying and managing cardiovascular-kidney-metabolic risks.
Micro-Learnings
Concise videos designed to address key topics or skills in CKM care in 15 minutes or less.
Podcasts
Listen and learn the latest recommendations and implementation strategies in daily clinical practice to ensure improved evidence-based care for individuals living with CKM syndrome.
CKM Health: Presidential Advisory Podcast
Co-chairs Drs. Ndumele and Rangaswami share insights on the CKMH presidential advisory—its creation, significance, and impact on health care. They highlight CKM stages, SDOH considerations, and breaking down care silos.
The Link between CKD and CVD Podcast Series
Patients with CKD exhibit an elevated risk for CVD. Early testing and diagnosis of CKD is key to prevention and better outcomes.
Listen to the 5-Part Series
Videos on Demand
Watch these Videos on Demand when it is most convenient for you.
The Role of Modern Algorithms in Cardiovascular Risk and Risk Assessment
GLP 1 RAs Selecting the Right Patient at the Right Time







Apps & Tools
Access tools to support CKM care

The American Heart Association PREVENT™ Online Calculator
Developed by the American Heart Association in 2023, the PREVENT equations estimate 10- and 30-year risk for total cardiovascular disease—including ASCVD and heart failure—by integrating cardiovascular, kidney, and metabolic health measures to guide primary prevention.
Guidelines-on-the-Go
The Guidelines-on-the-Go App features the 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy, plus so much more.
Cardiovascular-Kidney-Metabolic Health Educational Resources
- Presidential Advisory: Cardiovascular-Kidney-Metabolic Health
- Cardiovascular-Kidney-Metabolic Health: A 2023 Presidential Advisory From the AHA Slide Set
- Scientific Statement: A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome
- Top Things to Know: A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome
- Scientific Statement Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic (CKM) Health
- Methods paper: Development and Validation of the American Heart Association’s PREVENT Equations
- Research Article: Prevalence of Cardiovascular-Kidney-Metabolic Stages in US Adolescents and Relationship to Social Determinants of Health
- Research Article: Sex Differences in Cardiovascular-Kidney-Metabolic Syndrome: 30-Year US Trends and Mortality Risks—Brief Report
- Review Article: Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
- Cardiovascular-Kidney-Metabolic Health: A 2023 Presidential Advisory From the AHA Slide Set
- AHA Clinical Slide Series adapted from: The 2023 Scientific Statement From the AHA: A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic Syndrome
- AHA Clinical Slide Series: Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney Metabolic Health